Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Financial Result, which it ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Trident Texofab Ltd has informed BSE that its Board Meeting scheduled for May 28, 2026 to approve the Audited Standalone Financial Results for Q4 and FY ended March 31, 2026 has been adjourned. The Audit Committee did not approve the financial results due to delay in preparation of the Financial Statement. Both the Audit Committee and Board meetings have been rescheduled to May 30, 2026. The trading window for designated persons remains closed till 48 hours after the results are published.
The delay in financial statement preparation raises concerns about timely disclosure and may signal internal control or operational issues. Shareholders should monitor for the revised results announcement on May 30, 2026.